First Time Loading...

Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 45.32 USD 0.78%
Updated: May 21, 2024

Halozyme Therapeutics Inc
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Halozyme Therapeutics Inc
EPS (Diluted) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Halozyme Therapeutics Inc
NASDAQ:HALO
EPS (Diluted)
$2
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$3
CAGR 3-Years
6%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$0
CAGR 3-Years
18%
CAGR 5-Years
-39%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$7
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$15
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$33
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
25%

See Also

What is Halozyme Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
2.5 USD

Based on the financial report for Mar 31, 2024, Halozyme Therapeutics Inc's EPS (Diluted) amounts to 2.5 USD.

What is Halozyme Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
31%

Over the last year, the EPS (Diluted) growth was 90%. The average annual EPS (Diluted) growth rates for Halozyme Therapeutics Inc have been 31% over the past three years .